Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 680.72B, Johnson & Johnson(JNJ) trades at $282.91. The stock has a price-to-earnings ratio of 43.35 and currently yields dividends of 1.85%.
On 2026-11-16, Johnson & Johnson(JNJ) stock traded between a low of $282.33 and a high of $290.40. Shares are currently priced at $282.91, which is +0.2% above the low and -2.6% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 7.94M, against a daily average of 7.77M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $290.40 and a 52-week low of $193.55.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $290.40 and a 52-week low of $193.55.
JNJ News
...
Johnson & Johnson (NYSE:JNJ) on Monday agreed to acquire Ollin Biosciences, a clinical-stage biopharmaceutical company focused on therapies for serious eye dise...
It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...
Analyst ratings
67%
of 27 ratingsMore JNJ News
Ollin’s main experimental drug is designed to treat eye diseases that can cause vision loss. The purchase marks an expansion into eye medicines for J&J, which a...
Innovent Biologics ( (HK:1801) ) has issued an update. Innovent Biologics said its partner Ollin Biosciences entered a definitive agreement to be acquired by J...
Blackstone (BX) announced that funds managed by Blackstone Life Sciences will provide $750M in development funding to Johnson & Johnson (JNJ) to support the Pha...
The deal adds OLN324, an investigational bispecific antibody for retinal vascular diseases. Reuters Johnson & Johnson JNJ 0.79 %increase; up pointing triangle...
Shares in U.S. medical giant Johnson & Johnson (JNJ) were higher in pre-market trading today on reports that it has set its sights on buying eye disease biotech...
J&J in discussions to buy Ollin Biosciences for up to $3.4B - report Nov 16, 2026, 12:21 AM ET Johnson & Johnson (JNJ) Stock By : Manshi Mamtora, CFA Johnson &...
Johnson & Johnson (NYSE: JNJ) agreed to invest in Francis Medical to support development of the Vanquish prostate cancer ablation device. The Vanquish system i...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.